Recent Updates
Recently added Catalysts
HSIC Positive Sentiment

Henry Schein to Participate in Upcoming Investor Conference in September

Tuesday, September 8, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Henry Schein, Inc. announced its participation in the Baird Global Healthcare Conference scheduled for September 15, 2026. The event will take place at the InterContinental Hotel in New York City, where the company will present at 12:15 p.m. EDT. Interested parties can access the presentation via live webcast on the company's investor relations website.

Market Sentiment Analysis

POSITIVE FACTORS

  • Henry Schein is participating in a prominent investor conference.
  • The company is recognized as the largest provider of healthcare solutions.
  • Live webcasts of the presentations will be available for broader access.

Full Press Release Details

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc., the world’s largest provider of healthcare solutions to office-based dental and medical practitioners, announced today that the Company will present at the following conference in September: Baird Global Healthcare Conference at the InterContinental Hotel, New York City on September 15, 2026, at 12:15 p.m. EDT. Henry Schein’s presentations can be heard via live webcast by visiting www.henryschein.com/IRwebcasts. Replays will be available on t

Frequently Asked Questions

When is Henry Schein's investor conference?

Henry Schein's investor conference is on September 15, 2026.

Where will the conference take place?

The conference will be held at the InterContinental Hotel in New York City.

How can I access Henry Schein's presentation?

The presentation can be accessed via live webcast on their investor relations website.

What time is Henry Schein's presentation scheduled?

Henry Schein's presentation is scheduled for 12:15 p.m. EDT.

ShareAdd on Google
Tags: HSIC Viatris Investor Conferences Healthcare Henry Schein Baird Global Healthcare Conference investor conference healthcare solutions live webcast
Last updated: Sep 8, 2026

Biotech snapshot

Cash runway
$157M liquidity · $0M/mo burn
Low dilution risk